Grantham, Mayo, Van Otterloo & Co (GMO)’s Entegris ENTG Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTG
Grantham, Mayo, Van Otterloo & Co (GMO)'s ENTG Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Entegris (ENTG) stake by 40% in Q2 2026, selling an estimated $6.96M and leaving 72,607 shares worth $13.1M. The position accounts for 0.03% of the portfolio, ranked #232.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ENTG in Q2 2018 and has held it in 13 quarters since. The position peaked at $39.8M in Q3 2025. 746 funds tracked by Wall St. Rank hold ENTG as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 72,607 shares of Entegris worth $13.1M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 48,257 Entegris shares in Q2 2026, an estimated $6.96M.
- Entegris made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #232 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Entegris in Q2 2018 and has held it in 13 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Entegris position peaked at $39.8M in Q3 2025.
- 746 funds tracked by Wall St. Rank held Entegris as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.